Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1559 (LINC01559) is a human long non-coding RNA transcript classified as a lincRNA, meaning it is a non-protein-coding RNA molecule transcribed from regions of the genome that do not overlap known coding genes[1][4][7][15]. LINC01559 is mapped to chromosome 12[10]. While the broad class of lincRNAs is involved in nuclear architecture, chromatin remodeling, and gene regulation, there is no direct functional or disease association characterized for LINC01559 at present[5][2][3][12]. Its aliases include C12orf36 and FLJ33810. If further molecular, disease, or drug interaction data emerge in future updates, this classification may be revised.
N/A — no drugs targeting LINC01559 are documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1559 (LINC01559).